Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

LNW

Light & Wonder Inc. (ASX – LNW) CDIs & Securities Update for January 2025

Light & Wonder Inc. (ASX: LNW) has released its Statement of CDIs on issue for the month of January 2025, revealing changes in the number of CDIs and other securities on the Australian Securities Exchange (ASX) compared to the previous month.

The total number of CDIs quoted on ASX at the end of January 2025 was 25,791,302, showing a decrease of 280,649 from the previous month's total of 26,071,951. This change was attributed to net transfers of securities between CDIs and Common Stock as quoted/held on NASDAQ.

In addition, the total number of issued securities not represented by CDIs quoted on ASX was 59,226,654 at the end of January 2025, reflecting a decrease of 891,767 from the previous month's total of 60,118,421. This change was explained as a result of transfers of securities between CDIs and Common Shares, decreases in Common Shares repurchased by the issuer's ongoing share repurchase program offset by an increase in total shares outstanding pursuant to the vesting of the issuer's outstanding RSUs and the exercise of previously issued options to Common Shares.

These figures illustrate the dynamic nature of Light & Wonder Inc.'s securities on the ASX and provide insight into the company's activities and market movements. Following these announcements, the company's shares moved -0.8%, and are now trading at a price of $97.02. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS